HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drunk Elephant Hit With Sobering Allegations Of Fraudulent Medical Claims

This article was originally published in The Rose Sheet

Executive Summary

A plaintiff in New York’s Southern District says Drunk Elephant’s claims about skin firming and other benefits, used to promote its $60 Shaba Complex Eye Serum, either are bogus or identify the product as an unapproved drug. A similar case against Beiersdorf/NIVEA is currently under appeal in California.


Related Content

Appeals Court To Hear Suit Alleging Nivea Lotion Is Unlawfully Marketed Drug
Beiersdorf Moves To Squash Suit Alleging NIVEA Firming Lotion Is An Unapproved Drug
Avon Beats Class Bid In Suit Challenging Anti-Aging Claims; Appeal Filed





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts